Background
==========

It is well known that DNA methylation has important effects on transcriptional regulation, chromosomal stability, genomic imprinting, and X-inactivation \[[@B1],[@B2]\]. It has been also shown to be associated with many human diseases, such as various types of cancer \[[@B3]-[@B11]\].

With the advances of BeadArray technology, genome-wide high-throughput methylation data can be easily generated by Illumina GoldenGate and Infinium Methylation Assays. After preprocessing steps, such as background correction and normalization, are applied to the raw fluorescent intensities, for each locus, from about 30 replicates in the same array a summarized *β*-value is generated as follows: $\frac{\text{max}\left\{ {M,0} \right\}}{\text{max}\left\{ {M,0} \right\} + \text{max}\left\{ {U,0} \right\} + 100}$, where *M*is the average signal from a methylated allele while *U*is that from unmethylated allele. The *β*-values are continuous numbers between 0 and 1, with 0 stands for totally unmethylated and 1 for completely methylated.

It has been shown that the *β*-value is rarely normally distributed \[[@B9],[@B12],[@B13]\]. Therefore the commonly used t-test for case control designs or ANOVA for multiple conditions are not the most powerful approaches when detecting differentially methylated loci. Observing this, Wang has proposed a model-based likelihood ratio test to detect differentially methylated loci for case and control data under the assumption that the *β*-value follows a three-component normal-uniform distribution \[[@B9]\]. Wang showed that for some situations, their proposed test was better than the simple t-test based on simulation studies.

However, in their method, Wang did not consider the effect of age, which has been shown highly associated with methylation \[[@B14],[@B15]\]. Noticing the importance of age effect, one may use a linear regression with age included as a covariate when analyze methylation data with multiple conditions, such as cancer types. However, the underlying assumption of equal variances may not be satisfied \[[@B13]\]. Therefore the commonly used linear regression method may not be appropriate.

In this paper, we consider methylation data with multiple conditions and propose a nonparametric method which incorporates the age effect in a way through the idea of combining p-values from independent tests \[[@B12],[@B16],[@B17]\]. More specifically, we first group subjects into several age groups based on their age; then for each age group, a nonparametric Kruskal-Wallis test is conducted for the given locus and the p-value is recorded. An overall p-value for that locus will be estimated through combining the p-values from all age groups. Using a real methylation data with three conditions and a simulation study, we show that the proposed test is more powerful than other methods, including linear regression.

Method
======

Proposed method
---------------

Assume there are *K*conditions and *G*age groups. For each age group *g (g = 1,2,\...,G)*, we apply the nonparametric Kruskal-Wallis test and obtain a p-value $p_{g}^{KW}$, then the overall p-value can be estimated by Fisher test \[[@B18]\]:

$$p_{KW} = \chi_{df = 2G}^{2}\left( {\chi^{2} > - 2\sum\limits_{g = 1}^{G}\text{log}\left( p_{g}^{KW} \right)} \right)$$

Combined ANOVA test
-------------------

Similarly, we can use ANOVA to replace KW test for each age group and obtain an overall p-value with $p_{g}^{KW}$ being replaced by the p-value $p_{g}^{ANOVA}$ from ANOVA test:

$$p_{ANOVA} = \chi_{df = 2G}^{2}\left( {\chi^{2} > - 2\sum\limits_{g = 1}^{G}\text{log}\left( p_{g}^{ANOVA} \right)} \right)$$

Combined median test
--------------------

Another nonparametric test is median test using the following statistic for each age group:

$M = 4\sum\limits_{k = 1}^{K}\frac{\left( {A_{k} - n_{k}/2} \right)^{2}}{n_{k}}$, where *A~k~*is the number of times that the ranks of individual observations from group k which excess the median from the pooled data, and *n~k~*is the sample size of group *k*. When the sample sizes are large, under the null hypothesis that all samples have the same median, the statistic M has a chi-square distribution with K-1 degrees of freedom. The overall p-value from the combined median test can be calculated:

$$p_{Median} = \chi_{df = 2G}^{2}\left( {\chi^{2} > - 2\sum\limits_{g = 1}^{G}\text{log}\left( p_{g}^{Median} \right)} \right)$$

Combined welch test
-------------------

We also consider the nonparametric Welch test. For each age group, we have the test statistic \[[@B19]\]:

$$W = \frac{\sum\limits_{k = 1}^{K}w_{k}\left( {{\overline{\overline{x}}}_{k} - \hat{\mu}} \right)^{2}/\left( {K - 1} \right)}{1 + \left\lbrack {2\left( {K - 2} \right)/\left( {K^{2} - 2} \right)} \right\rbrack\sum\limits_{k = 1}^{K}h_{k}},$$

where $w_{k} = n_{k}/s_{k}^{2},\ \hat{\mu}\text{~=~}\sum\limits_{k = 1}^{K}w_{k}{\overline{x}}_{k}/w,\text{~w~=~}\sum\limits_{k = 1}^{K}w_{k},\ \text{h}_{k} = \left( {1 - w_{k}/w^{2}} \right)/\left( {n_{k} - 1} \right)$.

Under the null hypothesis, the statistic W is asymptotically distributed as F-distribution with *K*-1 and $\text{f~=~(}\text{K}^{2}\text{~-~1)/(3}\sum\limits_{k = 1}^{K}h_{k}\text{)}$ degrees of freedom. Welch test is an improvement of the Cochran test \[[@B20]\] which usually has inflated type I error rate especially for small sample sizes \[[@B19],[@B21]\]. The overall p-value from the combined Welch test is:

$$p_{Welch} = \chi_{df = 2G}^{2}\left( {\chi^{2} > - 2\sum\limits_{g = 1}^{G}\text{log}\left( p_{g}^{Welch} \right)} \right)$$

Methods for combining p-values
------------------------------

Besides the Fisher method mentioned above, we also consider Z-test to combine p-values from independent tests. First we calculated the weighted Z statistic using individual p-values from each age group: $Z = \sum\limits_{g = 1}^{G}n_{g}\Phi^{- 1}\left( {1 - p_{g}} \right)/\sum\limits_{g = 1}^{G}n_{g}^{2}$, where *n~g~*is the total sample size in age group *g*and Φ is the cumulative distribution function (CDF) of the standard normal distribution. It is easy to see that this statistic has standard normal distribution under the null hypothesis. The overall p-value is calculated by 1- Φ(Z). Note that here we use one-sided test to obtain the overall p-value.

Simulation settings
-------------------

To compare each method applied to an individual age group, we simulate *β*-value for three treatment groups based on beta distribution with parameters *a*and *b*, beta (*a,b*), and truncated normal distribution on (0,1) with parameters μ, σ^2^, TN(μ, σ^2^). We assume the sample sizes (denoted as *s*in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} for the simulation results) for the three treatments are either balanced: *s*= 30 for each, or non-balanced: *s*= 20, 30, and 40. First we compare the estimated type I error rates with the given significance level of 0.05 under the null hypothesis of no differences among treatment groups. Then we compare the empirical powers from each method under various situations. The empirical power is the proportion of rejected null hypothesis to the number of replicates.

###### 

Estimated type I error rates at significance level 0.05 with 10000 replicates.

  Distribution (sample sizes, parameters)                    ANOVA   median   Welch   KW
  ---------------------------------------------------------- ------- -------- ------- -------
  Beta (*s*= 30,30,30, *a*= 1,1,1, *b*= 2,2,2)               0.048   0.040    0.052   0.047
  Beta (*s*= 30,30,30, *a*= 1,1,1, *b*= 10,10,10)            0.052   0.044    0.053   0.051
  Beta (*s*= 30,30,30, *a*= 10,10,10, *b*= 1,1,1)            0.047   0.044    0.052   0.048
  Beta (*s*= 30,30,30, *a*= 10,10,10, *b*= 10,10,10)         0.045   0.045    0.047   0.046
  Beta (*s*= 20,30,40, *a*= 1,1,1, *b*= 2,2,2)               0.053   0.052    0.050   0.053
  Beta (*s*= 20,30,40, *a*= 1,1,1, *b*= 10,10,10)            0.049   0.049    0.054   0.048
  Beta (*s*= 20,30,40, *a*= 10,10,10, *b*= 1,1,1)            0.045   0.049    0.056   0.044
  Beta (*s*= 20,30,40, *a*= 10,10,10, *b*= 10,10,10)         0.050   0.051    0.043   0.052
  TN (*s*= 30,30,30, μ = 0.5,0.5, 0.5, σ^2^= 0.1,0.1,0.1)    0.050   0.044    0.053   0.045
  TN(*s*= 30,30,30, μ = 0.5, 0.5, 0.5, σ^2^= 0.1,0.2,0.3)    0.053   0.067    0.047   0.053
  TN (*s*= 20,30,40, μ = 0.5, 0.5, 0.5, σ^2^= 0.1,0.1,0.1)   0.050   0.052    0.052   0.049
  TN(*s*= 20,30,40, μ = 0.5, 0.5, 0.5, σ^2^= 0.1,0.2,0.3)    0.047   0.054    0.051   0.043

###### 

Empirical power at significance level 0.05 with 10000 replicates.

  Distribution (sample sizes, parameters)                     ANOVA       median   Welch       KW
  ----------------------------------------------------------- ----------- -------- ----------- -----------
  Beta (*s*= 30, 30,30, *a*= 5,5,5,*b*= 20,25,30              **0.821**   0.576    0.810       0.775
  Beta(*s*= 30, 30,30, *a*= 1.5,2,2.5, *b*= 20,20,20          0.650       0.504    0.648       **0.710**
  Beta (*s*= 30, 30,30, *a*= 20,20,20, *b*= 1.5,2,2.5,        0.658       0.495    0.656       **0.713**
  Beta (*s*= 20,30,40, *a*= 5,5,5, *b*= 20,25,30)             **0.792**   0.546    0.740       0.735
  Beta (*s*= 20,30,40, *a*= 1.5,2,2.5, *b*= 20,20,20)         0.599       0.479    0.634       **0.670**
  Beta (*s*= 20,30,40, *a*= 20,20,20, *b*= 1.5,2,2.5)         0.607       0.475    0.637       **0.665**
  TN (*s*= 30, 30,30, μ = 0.45,0.5,0.55, σ^2^= 0.2)           **0.383**   0.240    0.378       0.362
  TN (*s*= 30, 30,30, μ = 0.45,0.5,0.55, σ^2^= 0.1,0.2,0.3)   0.338       0.325    **0.412**   0.341
  TN (*s*= 20,30,40, μ = 0.45,0.5,0.55, σ^2^= 0.2)            **0.349**   0.238    0.343       0.328
  TN (*s*= 20,30,40, μ = 0.45,0.5,0.55, σ^2^= 0.1,0.2,0.3)    0.219       0.361    **0.423**   0.259

A real data set
---------------

We will use a real methylation data set, the United Kingdom Ovarian Cancer Population Study (UKOPS) \[[@B15]\] with 274 controls, 131 pre-treatment cases, and 135 post treatment cases, to compare the performance of the proposed test with others. Those methylation data were generated by the Illumina Infinium Huamn Methylaytion27 BeadChip and can be downloaded under accession number GSE19711 from the NCBI Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo>).

For this data set, there are 27578 loci. After data quality control process, we removed some subjects with BS values less than 4000 or the coverage rates less than 95%. We also separate subjects into 6 age groups (50-55, 55-60, 60-65, 65-70, 70-75, and 75 and over). Table [3](#T3){ref-type="table"} gives the numbers of subjects in each age by treatment groups. For each locus, we perform the above mentioned approaches.

###### 

Number of samples in age group by treatment group used in the paper after removing subjects with bs \<4000 or coverage rate \<95% or age \>80.

  Age group   control   Pre-treat   Post-treat   Total
  ----------- --------- ----------- ------------ -------
  50_55       14        15          16           45
  55_60       61        17          25           103
  60_65       64        17          22           103
  65_70       35        17          21           73
  70_75       63        24          22           109
  75_over     20        18          9            47
  Total       257       108         115          480

Results
=======

Simulation results
------------------

Table [1](#T1){ref-type="table"} reports the estimated type I error rates from each method under different conditions. For most of the time, the estimated type I error rates are close to the nominal significance level as expected. Table [2](#T2){ref-type="table"} gives the empirical powers from each method. It can be seen that the non-parametric method of Mood\'s median test usually has the lowest powers in the simulations. None of the ANOVA, Welch and KW tests is uniformly most powerful. In words, their performances depend on the distributions from which the data are generated. From our simulation study, the KW test is usually as powerful as or more powerful than the ANOVA test. The true distributions of the *β*-value may vary from locus to locus; it is impossible to simulate all possible distributions. However, based on the observation of the real data, we know that the distributions of the *β*-value are far from the normal distribution, under which ANOVA is the best test. Therefore, we prefer nonparametric tests which are more robust.

Results from real data set
--------------------------

For the real data set, we applied the above mentioned methods to get the overall p-values (either using Fisher or Z test to combine p-values from individual age groups) for each locus. Then we use various cutoff p-values, 0.001, 0.0001, 0.00001, and 0.000001, to count how many loci have smaller p-values for each method. Table [4](#T4){ref-type="table"} reports the results. We can see that the KW method usually finds more significant loci than other methods. It also shows that the two combining p-value methods, Fisher and Z test have similar performances, although Z test usually give a little bit more significant loci expect for the Median test. Figure [1](#F1){ref-type="fig"} plots the negative log10 p-values from pairs of the methods. It shows that the KW method gives smaller p-values especially when the differences among the three treatment groups are not large (e.g., the negative log10 p-values between 3 and 6). From Figure [1](#F1){ref-type="fig"} we can see that for a given cutoff p-value, most of the loci identified by ANOVA test or Median were also detected by the Welch test; in turn, most of the loci identified by Welch test were also detected by the KW test. This indicates the KW test is more powerful than other methods compared.

###### 

Number of significant differentially methylated loci detected for given cutoff p-value based on the real data.

  Method   1e-3       1e-4       1e-5      1e-6                                    
  -------- ---------- ---------- --------- --------- --------- --------- --------- ---------
  ANOVA    981        1079       655       690       479       499       350       375
  Median   906        893        464       449       255       240       143       127
  Welch    1096       1106       640       673       416       424       281       289
  K-W      **1359**   **1340**   **823**   **859**   **551**   **590**   **381**   **401**

![**Negative log10(p-value) from pair of methods**. Negative log10 p-values from pair of methods. (a) Combined ANOVA test vs. combined median test both using Fisher methods to combine p-values. (b) Combined ANOVA test vs. combined Welch test both using Fisher methods to combine p-values. (c) Combined ANOVA test vs. combined Kruskal-Willas test both using Fisher methods to combine p-values. (d) Combined KW test using Z test vs. combined KW test using Fisher to combine p-values.](1755-8794-6-S1-S9-1){#F1}

Discussion and conclusions
==========================

Due to the unique feature of the *β*-value of methylation data, traditional statistical methods, such as linear regression and ANOVA test may not be appropriate. It has been shown that methylation is highly correlated with age; ignoring age effect may cause many false positives and/or false negatives. The effect of age may also not be linear; therefore we need a better way to account for this effect. In this paper, we use p-value combination method to deal with age effect. For each age group, we use nonparametric method to compare the treatment groups. It is important to find powerful and robust nonparametric methods for this sort of data. Although we found that KW method is more powerful than some other nonparametric methods for methylation data, it is desirable to find more powerful tests in this area. Furthermore, we want to point out that there are many other methods can be used to combine p-values \[[@B22],[@B23]\]; it may also be possible to find a more powerful method to combine p-values for Illumina Array Methylation data. However, based on our experiences, Fisher test is more robust and can be used in situations when a small portion of the p-values are very small; while the Z test is more powerful when the effect sizes are similar (e.g., the p-values don\'t differ much) for all of the age groups. Finally, although in this paper we use different cutoff p-values to compare the performance of tests, one may want to control the false positive rate. Several multiple comparison methods have been proposed for large scale data set to deal with the situations where the variables (loci) are not independent \[[@B24]-[@B28]\]. However, it remains to study which approach is more appropriate for the methylation data.
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